Waktu Penggunaan Depo Medroxy Progesterone Acetate terhadap Peningkatan Indeks Massa Tubuh (IMT) Ibu di Puskesmas Talise Kota Palu
Depo medroxy progesterone acetate (DMPA) can cause an increase in Body Mass Index (BMI). The purpose of this study was to determine the effect of the use of depro medroxy progesterone acetate on increasing IMT. Observational research design with cross sectional approach. The study was conducted at the Talise Health Center in Palu, Mantikulore District, Palu, Central Sulawesi, on July 0-31, 2017. The population was all women of childbearing age who had 3 months of injecting birth control with a population of 84 acceptors. Using the Slovin formula, a sample size of 69 was obtained. Sampling with a purposive sampling technique. The research instrument used questionnaires and weight scales. Univariate and bivariate data analysis. Correlation analysis and simple linear regression showed the influence of the time of use of DMPA contraception to increase BMI has a significant relationship p-value <0.05 with a correlation coefficient of 0.513 with a strong relationship, and the t value of 4.886 is greater than t table of 1.996 this means that the time DPMA use has an effect on weight gain. The linear regression equation obtained is Y = -0,984 + 0,259.X. From this study it can be concluded that the use of DPMA contraception affects the increase in maternal IMT at Talise Health Center. It is recommended for midwives to be able to provide counselors to acceptors about the side effects of contraception, so that acceptors are more selective in choosing contraception